Phase II study of 852A administered subcutaneously in pa

Project: Research project

Project Details

Description

Phase II study of 852A administered subcutaneously in patients
StatusFinished
Effective start/end date4/13/066/30/14

Funding

  • COLEY PHARM GROUP

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.